Canada Pension Plan Investment Board Acquires Shares of 3,919,153 Kenvue Inc. $KVUE

Canada Pension Plan Investment Board acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,919,153 shares of the company’s stock, valued at approximately $74,895,000.

Several other hedge funds and other institutional investors also recently modified their holdings of KVUE. Callan Family Office LLC bought a new stake in Kenvue in the 2nd quarter valued at about $835,000. Calamos Advisors LLC grew its position in Kenvue by 24.1% in the 1st quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock worth $57,771,000 after purchasing an additional 651,000 shares during the last quarter. State of Wyoming grew its position in Kenvue by 233.5% in the 4th quarter. State of Wyoming now owns 97,992 shares of the company’s stock worth $1,690,000 after purchasing an additional 68,609 shares during the last quarter. Nomura Asset Management Co. Ltd. increased its stake in shares of Kenvue by 21.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock valued at $60,229,000 after purchasing an additional 618,720 shares during the period. Finally, Nuance Investments LLC acquired a new stake in shares of Kenvue in the second quarter valued at approximately $27,681,000. Institutional investors own 97.64% of the company’s stock.

Kenvue Price Performance

Shares of NYSE KVUE opened at $19.23 on Thursday. The firm has a 50-day moving average of $19.12 and a two-hundred day moving average of $18.23. The company has a market capitalization of $36.94 billion, a price-to-earnings ratio of 22.10, a PEG ratio of 1.38 and a beta of 0.47. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $20.95.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The business had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. During the same quarter in the previous year, the firm earned $0.29 earnings per share. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th were given a $0.21 dividend. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s dividend payout ratio is 96.55%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on KVUE shares. Barclays increased their price objective on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Wall Street Zen cut Kenvue from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. UBS Group cut their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Finally, Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $19.27.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.